Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate (2007-5904)

This study is not yet open for participant recruitment.
Information provided by University of California, Irvine

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Prostate Cancer
2		Additional conditions recognized in this trial
			Prostatic Neoplasms
3		More general conditions related to this trial
			Genital Diseases, Male
			Genital Neoplasms, Male
			Neoplasms
			Neoplasms by Site
			Prostatic Diseases
			Urogenital Neoplasms
4		Interventions listed in this trial
			Docetaxel plus prednisone
5		Additional drug interventions recognized in this trial
			Docetaxel
			Prednisone
6		More general drug interventions related to this trial
			Anti-Inflammatory Agents
			Antineoplastic Agents
			Antineoplastic Agents, Hormonal
			Glucocorticoids
			Hormones
			Hormones, Hormone Substitutes, and Hormone Antagonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			University of California, Irvine